baber/WOPTO huggingface dataset:
Patent AT-E247544-T1 (AT)
Inventor: KNUDSEN KARIN
IPC: B29K23/00
Filed: 1999-12-10
Granted: 2003-09-15
Abstract: Rotational moulded products are prepared by producing a mixture of a polyolefin and optionally at least one additive, extruding this mixture in melt form through orifices in a die, pelletizing the mixture extruded through the orifices to form micropellets having a particle size distribution D(v, 0.5) of 0.1 to 1 mm, and a value of the ratio of D(v, 0.9)-D(v, 0.1) to D(v, 0.5) of no more than 1, drying the micropellets to a residual water content of no more than 1% weight, and if desired packaging the micropellets.
Patent AT-E288006-T1 (AT)
Inventor: POHJALAINEN AULIS
IPC: E04H12/08
Filed: 1999-11-12
Granted: 2005-02-15
Abstract: The invention relates to a mast structure for wireless appliance such as the base station of a mobile phone network. The structure comprises a tubular mast body (1) and at least one fixing spreader frame (22) for support wires (14). The fixing frame forms a structure encircling the tubular body (1) and comprises at least three support wire fix points (23, 24, 25) spaced appart from the tubular body (1) and from each other and e.g. five support wires (14) per frame (22) anchored to the ground for supporting the tubular body (1) via the fixing spreader frame. The structure further comprises means (26, 27) for fastening the fixing spreader frame (22) to the tubular body (1). The invention also concerns a method in relation to a mast structure.
Patent DE-05024834-T1 (DE)
Title: Verfahren und System zur thermischen Handhabung
Inventor: LAMB JOHN S
IPC: H02J3/14
Filed: 2005-11-14
Abstract: Verfahren
zur thermischen Handhabung, umfassend:  Abfühlen einer Temperatur;  Vergleichen
der Temperatur mit einer ersten vorgegebenen Temperatur; und  Deaktivieren
einer Last mit niedrigster Priorität in Reaktion auf die Temperatur,
die gleich ist zu der ersten vorgegebenen Temperatur.
Patent DE-09160876-T1 (DE)
Title: Flammhemmender Stoff
Inventor: ROCK MOSHE
IPC: D03D15/12
Filed: 2009-05-21
Abstract: Stoffartikel von gestrickter oder gewebter Konstruktion, wobei der Stoffartikel aufweist:  einen Stoffkörper von verschlungenen Garnen mit schwer entflammbarem Material, wobei der Stoffkörper eine Innenfläche und eine Außenfläche hat, wobei auf der Innenfläche wenigstens ein Bereich mit Faserflor oder aufgerauten Fasern oder Fleece ausgebildet ist, und wobei die Außenfläche eine schwer entflammbare Beschichtung aufweist, die an den Garnen und/oder Fasern der Garne wenigstens an Verschlingungs-Schnittpunkten anhaftet.
Patent DE-19680785-T1 (DE)
Inventor: NEMOTO SHIN
IPC: G01R31/28
Filed: 1996-07-29
Abstract: A semiconductor device testing system is provided which can efficiently utilize a plurality of semiconductor device testing apparatus. There are provided a host computer 2 for controlling a plurality of semiconductor device testing apparatus 1A, 1B, and 1C, and a dedicated classifying machine 3. Storage information memory means 4 for storing storage information of each semiconductor device such as a number assigned to each tested semiconductor device, the test results of each semiconductor device, and the like is provided in the host computer 2. Without sorting the tested devices or with the sorting operation of the tested devices into only two categories in the handler part 11 of each testing apparatus, the tested devices are transferred from the test tray to a general-purpose tray, and during this transfer operation, the storage information of each device is stored in the storage information memory means. When all the tests are completed, the storage information of each device stored in the storage information memory means is transmitted to the dedicated classifying machine by which the tested devices are sorted out.
Patent DE-22166227-T1 (DE)
Title: Entwässerung eines polysaccharidhaltigen Biomassematerials, Verfahren zur Extraktion von Polsaccharid aus Biomassematerial und entwässertes Biomassematerial
Inventor: OLSEN HELLE BECH
IPC: A23L29/20
Filed: 2010-07-07
Abstract: Ein entwässertes Biomasse-Material, das ein Polysaccharid beinhaltet, wobei das entwässerte Biomasse-Material Trockenmasse in einer Menge von 35 Gew.-% bis 60 Gew.-% des entwässerten Biomasse-Materials und einen Restzuckergehalt von 3 Gew.-% bis 30 Gew.-% des entwässerten Biomasse-Materials beinhaltet.
Patent DE-77887-T1 (DE)
IPC: H01H13/70
Filed: 1982-08-04
Abstract: Custom membrane switch assemblies comprising a plurality of switch modules of different sizes.
Patent DE-96617-T1 (DE)
IPC: C22C32/00
Filed: 1983-05-25
Abstract: 1. A solide practice bullet made of plastics (1) loaded with metal or alloy particles (2) distributed uniformly in the plastics, the particle content being such that the density of the bullet is from 3 to 5, characterized in that the particles (2) are ductile and the plastics (1) also contains (3) of a solid lubrifiant.
Patent DE-149935-T1 (DE)
IPC: B60B7/06
Filed: 1984-12-12
Abstract: 1. Device for the removable fastening of an ornemental cap (1) on a rim (5) of a wheel (2) through the medium of an independent and resiliently deformable ring (3) which may be anchored onto the wheel rim, characterized in that the said ring comprises a web (9) connected through a strip of material (10) to a thin annular lip (8) more resilient than the web (9) for allowing the clipping of the ring (3) through force-fitting and setting of the lip (8) into an annular step (4) of the wheel rim, the said web (9) forming with the lip (8) an annular groove (12) exhibiting substantially a V-shape, and being connected to the ornamental cap (1) by fastenings (7) or fingers (17) solid with the web and clipped into housings (15, 16) provided on the inner face (1a) of the ornamental cap (1).
Patent DE-213657-T1 (DE)
IPC: H02H9/00
Filed: 1986-07-28
Abstract: An overvoltage protective device specifically designed for non-symmetric transmission circuits, such as coaxial lines. A coiled section (13.1-6) of a coaxial line (8.1-6) branched off from a coaxial cable (6) wound with a number of turns is disposed within a fully closed second compartment (4) of a metal housing (1). Such a coiled section of a coaxial line together with one or more voltage-dependent current conducting components (16, 17) connected to the outer conductor of said coaxial line (8.1-6), forms a filter which effectively attenuates spurious radiation from said outer conductor at the output side of said filter, said radiation being caused by a destructive EM-pulse. The transmission characteristics of the coaxial line (8.1-6) including said coiled section (13.1-6) are not detrimentally affected by such a filter. An overvoltage protective according to the invention makes it, by its structure, feasible to lead one or more coaxial transmission lines through a wall portion of an enclosed space of the Faraday cage type, while on the other hand an effective protection is provided against destructive radiation such as caused by an EM-pulse.
Patent DE-851876-T1 (DE)
Inventor: LOENNROTH IVAR
IPC: A23K1/165
Filed: 1996-08-23
Abstract: A new recombinant protein called Antisecretory Factor (rAF) and homologues and peptide fragments thereof are described. The protein and the homologues and fragments thereof are useful for normalizing pathological fluid transport and/or inflammatory reactions in animals including humans. Antibodics against AF or homologues or fragments thereof are described. Nucleic acids coding for the protein or for homologues or fragments thereof are also described as well as vectors and hosts comprising the nucleic acids. The rAF and homologues and fragments thereof could be used for immunodetection, as feed additive for growing animals and as antidiarrheal and drugs against diseases involving edema, dehydration and/or inflammation.
Patent DE-1015126-T1 (DE)
Inventor: CORNAY PAUL JOSEPH
IPC: B04B11/02
Filed: 1997-10-15
Abstract: A centrifuge for decanting lighter material from heavier material from a mixture of initial material includes a housing having a central body and a hollow arm extending from the body, the arm having a first end attached to the central body, and a second end extending away from the central body, and an end cap attached to the second end of the arm to form a chamber in the arm. A baffle is attached to the body and extends into the chamber, the baffle having a longer inner tube having an interior and a distal end, and a shorter outer tube. The longer tube is positioned inside the shorter tube and defines an inner space therebetween. An outer space is defined between the shorter tube and the hollow arm. An entrance path for the mixture of initial material is formed in the housing and communicates with the inner space. An exit path for the light material is formed in the housing and communicates with the outer space. An exit path for the heavier material is formed in the housing and includes the interior of the longer tube. A plug is formed in the chamber adjacent the end cap to engage the distal end of the longer tube and define a flow path to guide the lighter material to the light material exit path.
Patent ES-2288811-T1 (ES)
Inventor: MENDEZ JUANA ARACELI
IPC: A61P21/02
Filed: 2006-09-13
Abstract: The invention encompasses processes for synthesizing 1-[17²-acetyloxy-3±-hydroxy-2²-(4-morpholinyl)-5±-androstan-16²-yl]-1-(2-propenyl)pyrrolidinim bromide (rocuronium bromide) and intermediates thereof.
Patent ES-2036510-T1 (ES)
Title: Procedimiento y dispositivo de cebado de cartuchos de municiones o cargas de cierre de percusion anular.
IPC: F42B5/32
Filed: 1992-02-19
Abstract: EL PROCESO PERMITE CEBAR VAINAS (1) DE MUNICIONES O CARGAS DE SELLADO DE PERCUSION ANULAR QUE COMPRENDE UN FONDO (2) CONECTADO A SU PARED LATERAL (3) POR UNA PESTAÑA ANULAR (4) QUE DEFINE EN EL INTERIOR DE LA VAINA UNA GARGANTA ANULAR (5) DESTINADO A RECIBIR LA COMPOSICION PIROTECNICA DE CEBADO (6). EL PROCESO CONSISTE EN DEPOSITAR EN EL FONDO DE LA VAINA DICHA COMPOSICION (6), Y EN INTRODUCIRLO A CONTINUACION EN DICHA GARGANTA (5). SEGUN LA INVENCION, SE INTRODUCE DICHA COMPOSICION EN DICHA GARGANTA (5) , SOMETIENDO LA COMPOSICION (6) DEPOSITADA EN EL FONDO (2) DE LA VAINA A UNA COMPRESION PROGRESIVA SEGUN UNA DIRECCION OBLICUA RESPECTO DEL EJE (X, X'') DE LA VAINA (1) Y DIRIGIDA HACIA LA GARGANTA (5), MEDIANTE UNA SUPERFICIE (8) QUE SE HACE GIRAR ALREDEDOR DEL EJE (X, X''). UTILIZACION EN PARTICULAR PARA MEJORAR LA SEGURIDAD Y LA CALIDAD DE LOS CEBOS DE VAINAS.
Patent ES-2149734-T1 (ES)
Inventor: PETERSEN HANS
IPC: C07D307/88
Filed: 1997-11-11
Abstract: A method for the preparation of citalopram is described comprising reaction of a compound of Formula (IV) wherein R1 is H or C1-6alkylcarbonyl successively with a Grignard reagent of 4-halogen-fluorophenyl and a Grignard reagent of 3-halogen-N,N-dimethylpropylamine, effecting ring closure of the resulting compound of Formula (IV) and converting the resulting 1,3-dihydroisobenzofuran compound to the corresponding 5-cyano derivative, i.e. citalopram.
Patent ES-2168238-T1 (ES)
Inventor: BLUMER HANS
IPC: B26D7/01
Filed: 1999-11-23
Abstract: The appliance for stacking flat structures (54) for punching out from a basic elongated, cube-shaped stack (26) contains a hollow cylindrical punching-tool (16). A punching element (14) in the form of a support plate forming part of a support bench (22) takes the basic stack for punching. A counter-pressure punch (18) moves to and fro towards the punching element and through the punching tool. The finished stack is removed sideways by a container. The end (46) of the support bench facing the support plate (20) has a slide unit (50) moving the basic stack towards the punching-tool. The end of the support bench facing the slide unit has an aligning element (44) which aligns the basic stack under the punching tool.
Patent CY-1112016-T1 (CY)
Inventor: BERCHTOLD HARALD
IPC: C07K14/62
Filed: 2010-05-13
Abstract: The invention relates to crystals of an insulin analogue, in which asparagine (Asn) in position B3 of the B chain is replaced by a naturally occurring basic amino acid residue, and at least one amino acid residue in positions B27, B28 or B29 of the B chain is replaced by another naturally occurring neutral or acid amino acid residue. According to the invention, phenylalanine (Phe) can optionally be absent in position B1 of the B chain, and the crystals exist in space group R3 (Nr. 146) with cell axes A=81.5 ANGSTROM +/- 1 ANGSTROM and C=33.3 ANGSTROM +/- 1 ANGSTROM . The invention also relates to the production and use of said crystals, and to a pharmaceutical composition containing these crystals.
Patent CY-1110995-T1 (CY)
Inventor: WELCH SIAO-KUN WAN
IPC: C07K14/18
Filed: 2010-12-16
Abstract: The present invention provides safe vaccines and methods of preparing such vaccines. The vaccines of the present invention contain at least two live mutant viruses of the same family or nucleic acid molecules encoding such viruses, wherein each of the two viruses or the encoding nucleic acids contains a mutation that confers a desirable phenotype and the mutations in the viruses reside in the same genomic site such that the mutant viruses cannot recombine with each other to eliminate the mutations.
Patent CY-1111612-T1 (CY)
Title: Μεθοδος για προβλεψη της αποκρισης σε μια θεραπευτικη αγωγη με εναν αναστολεαδιmερισmου του her
Inventor: MOECKS JOACHIM
IPC: G01N33/574
Filed: 2011-03-15
Abstract: Η εφεύρεση αναφέρεται σε μια μέθοδο πρόβλεψης της απόκρισης ενός ασθενούς σε μια θεραπευτική αγωγή με ένα αναστολέα διμερισμού του HER η οποία μέθοδος περιλαμβάνει τα στάδια της αποτίμησης ενός γονιδίου δείκτη ή ενός συνδυασμού γονιδίων δεικτών που επιλέγονται από την ομάδα την αποτελούμενη από έναν επιδερμικό αυξητικό παράγοντα, έναν αυξητικό παράγοντα μετασχηματισμού άλφα και ένα HER2 γονίδιο δείκτη ή έναν συνδυασμό γονιδίων δεικτών που περιλαμβάνει ένα γονίδιο δείκτη αμφιρεγουλίνης και ένα γονίδιο δείκτη που επιλέγεται από έναν επιδερμικό αυξητικό παράγοντα, έναν αυξητικό παράγοντα μετασχηματισμού άλφα και ένα HER2 γονίδιο δείκτη σε ένα βιολογικό δείγμα από τον ασθενή και πρόβλεψη της απόκρισης του ασθενούς σε μια θεραπευτική αγωγή με έναν αναστολέα διμερισμού του HER με αξιολόγηση των αποτελεσμάτων του πρώτου σταδίου. Αποκαλύπτονται περαιτέρω χρήσεις και μέθοδοι όπου χρησιμοποιούνται αυτοί οι δείκτες.
Patent CY-1111722-T1 (CY)
Title: Νεες ενωσεις κυκλοεξενονης απο antrodia camphorata και εφαρμογες αυτων
Inventor: LIU SHENG-YUNG
IPC: C07C403/22
Filed: 2011-07-20
Abstract: Η παρούσα εφεύρεση αφορά μία νέα ένωση και τις χρήσεις αυτής, η οποία είναι ένα εκχύλισμα απομονωμένο και καθοριζόμενο από Antrodia camphorata, ειδικότερα εις την 4-υδροξυ-2,3-διμεθοξυ-6-μεθυλο-5(3,7,11-τριμεθυλο-δωδεκα-2,6,10-τριενυλο)-κυκλοεξ-2-ενόνη και την χρήση αυτής εις την αναστολή της ανάπτυξης όγκου. Η ένωση της εφεύρεσης, η οποία δεν είχε ποτέ ανακαλυφθεί στο Antrodia camphorata, μπορεί να εφαρμοσθεί στην αναστολή της ανάπτυξης των καρκινικών κυττάρων όπως του καρκίνου του μαστού, του καρκίνου του ήπατος, του καρκίνου του προστάτη και μπορεί να χρησιμοποιηθεί ως φαρμακευτική σύνθεση για να αναστέλλει την ανάπτυξη όγκου- ή επιπλέον να εφαρμοσθεί στην πρόληψη της καρδιαγγειακής νόσου ή σε διατροφικά συμπληρώματα για λόγους υγείας εξαιτίας της αντιοξειδωτικής της δράσης.
Patent CY-1116319-T1 (CY)
Title: Συνθεσεις που περιλαμβανουν core-1 θετικο μικροοργανισμο και χρηση αυτων για την αντιμετωπιση ή προφυλαξη απο ογκους
Inventor: GOLETZ STEFFEN
IPC: C12R1/19
Filed: 2015-04-08
Abstract: Η παρούσα εφεύρεση σχετίζεται με το πεδίο της πρόληψης και αντιμετώπισης γαστρεντερικών διαταραχών. Πιο συγκεκριμένα, η παρούσα εφεύρεση σχετίζεται με την πρόληψη και αντιμετώπιση Core-1 θετικών καρκινωμάτων. Σχετίζεται με κορεοτικά και τη μέθοδο παραγωγής τους και τη μέθοδο πρόληψης και αντιμετώπισης Core-1 θετικών διαταραχών με χρήση κορεοτικών.
Patent CY-1120256-T1 (CY)
Title: Παραγωγο 5-υδροξυ-4-(τριφθορομεθυλ)πυραζολοπυριδινης
Inventor: KOBAYASHI HIDEKI
IPC: C07D471/04
Filed: 2018-05-23
Abstract: Ένωση η οποία έχει εξαιρετικά αποτελέσματα ενεργοποίησης LCAT, είναι χρήσιμη ως δραστικό συστατικό ενός θεραπευτικού ή προληπτικού παράγοντα για αρτηριοσκλήρωση, αρτηριοσκληρωτική καρδιαγγειακή ασθένεια, στεφανιαία καρδιακή ασθένεια (που συμπεριλαμβάνει καρδιακή ανεπάρκεια, μυοκαρδιακή απόφραξη, στηθάγχη, καρδιακή ισχαιμία, καρδιαγγειακή διαταραχή και αγγειοπλαστική επαναστένωση), παρεγκεφαλιδοαγγειακή ασθένεια (που συμπεριλαμβάνει εγκεφαλική συμφόρηση και εγκεφαλική απόφραξη), περιφερική αγγειακή ασθένεια (που συμπεριλαμβάνει διαβητική αγγειακή επιπλοκή), δυσλιπιδαιμία, χαμηλής HDL χοληστερόλη, υψηλή HDL χοληστερόλη ή ασθένεια νεφρού, ιδιαιτέρως, έναν κατά της αρτηριοσκλήρωσης παράγοντα, και αντιπροσωπεύεται με το γενικό τύπο (I) (I) [Στον τύπο, R είναι αρύλ ομάδα η οποία μπορεί να είναι υποκατεστημένη ή ετεροαρύλ ομάδα η οποία μπορεί να είναι υποκατεστημένη και R1 είναι άτομο υδρογόνου ή υδροξύλ ομάδα.] ή φαρμακολογικώς αποδεκτό άλας αυτής.
Patent CY-1123187-T1 (CY)
Title: Θεραπευτικες μεθοδοι που αφορουν βλαστοκυτταρα καρκινου
Inventor: FRANK MARKUS H
IPC: G01N33/574
Filed: 2020-05-08
Abstract: Αποκαλύπτονται γονίδια που είναι δυσρυθμισμένα σε βλαστοκύτταρα καρκίνου (π.χ., βλαστοκύτταρα μελανώματος). Μέθοδοι που περιλαμβάνουν ρύθμιση (π.χ., διέγερση, αναστολή, κ.λπ.) της δραστικότητας των σχετικών με βλαστοκύτταρο καρκίνου γονίδια χρησιμοποιούνται για να θεραπεύονται άτομα που έχουν μελάνωμα. Γονίδια επιφάνειας κυττάρου τα οποία είναι προς τα πάνω ρυθμισμένα σε βλαστοκύτταρα καρκίνου στοχεύονται για την εκλεκτική απομόνωση, ανίχνευση και θανάτωση βλαστοκυττάρων καρκίνου σε μελάνωμα.
Patent CY-1123163-T1 (CY)
Title: Αντισωματα που δεσμευουν beta klotho επικρατεια 2 και μεθοδοι χρησης αυτων
Inventor: MONDAL KALYANI
IPC: C07K16/28
Filed: 2020-07-29
Abstract: Η παρούσα αποκάλυψη παρέχει πρωτεΐνες δέσμευσης όπως αντισώματα που δεσμεύονται με beta klotho, συμπεριλαμβανομένης ανθρώπινης beta klotho, και μεθόδους χρήσης αυτών.
Patent GR-930300080-T1 (GR)
Title: Sinterable carbon powder and method of making it.
Inventor: BOENIGK WINFRIED DR
IPC: C10C3/06
Filed: 1993-10-31
Abstract: For binder-free preparation of carbon articles, a carbon powder with 40 to 75% by weight of QI, more than 90% by weight of TI, an optical anisotropy of less than 50% by volume, an initial softening point between 200 and 300 DEG C and an oxygen content of more than 2% by weight is proposed. The carbon powder is prepared from bituminous products by distillation at a maximum of 5 mbar and an end temperature of at least 400 DEG C, grinding of the distillation residue to a particle size of less than 30  mu m and oxidation of the powder right into the particle core.
Patent HR-P20100104-T1 (HR)
Title: Combinations comprising antimuscarinic agents and corticosteroids
Inventor: ESCARDO JORDI GRAS
IPC: A61P11/08
Filed: 2010-02-26
Abstract: A combination which comprises (a) a PDE4 inhibitor and (b) an antagonist of M3 muscarinic receptors which is (3R)-1-phenethyl-3-(9H-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2]octane, in the form of a salt having an anion X, which is a pharmaceutically acceptable anion of a mono or polyvalent acid.
Patent HR-P20110047-T1 (HR)
Inventor: NORDVALL GUNNAR
IPC: A61P11/06
Filed: 2011-01-21
Abstract: Spoj, naznačen time, da je prikazan formulom (I) R1 predstavlja CH3 ili CH3CH2;R2 predstavlja H, 2-F, 2-Cl, 3-F, 3-OCH3, 3-CN, 3-CF3, 3-CONH2 ili 3-SO2CH3;R3 predstavlja H ili CH3;R4 predstavlja H ili CH3; iR5 predstavlja H; ili kada R4 je CH3, R5 predstavlja H ili F; i njegove farmaceutski prihvatljive soli. Patent sadrži još 17 patentnih zahtjeva.
Patent HR-P20120624-T1 (HR)
Inventor: XIAOMING ZHOU
IPC: A61K31/4468
Filed: 2012-07-31
Abstract: Spoj formule IA: naznačen time daA je aril ili heteroaril; R1 je: H ili halo; ili-O-C1-6alkil, koji je proizvoljno supstituiran; ili-NR6R7, pri čemu svaki R6 i R7 je nezavisno odabran iz skupine koja sadrži H ili C1-6alkil, C2-6alkenil, te C2-6alkinil; svaki od kojih je proizvoljno supstituiran, R2 je C1-6alkil, C2-6alkenil, C2-6alkinil, -C(=O)C1-6alkil, -C(=O)C2-6alkenil, -C(=O)C2-6alkinil, -S(=O)C1-6alkil, -S(=O)C2-6alkenil, -S(=O)C2-6alkinil, SO2C1-6alkil, SO2C2-6alkenil, SO2C2-6alkinil, -CO2C1-6alkil, -CO2C2-6alkenil ili -CO2C2-6alkinil, svaki od kojih je proizvoljno supstituiran; pri čemu proizvoljno supstituiran znači da je skupina proizvoljno supstituirana sa jednim ili više supstituenata, poželjno 1, 2 ili 3 supstituenta, nezavisno odabrana iz skupine koja sadrži halo, halo(C1-6)alkil, halo2(C1-6)alkil, halo3(C1-6)alkil, aril, heteroaril, cikloalkil, heterocikloalkil, C1-6alkil, C2-6alkenil, C2-6alkinil, aril(C1-6)alkil, aril(C2-6)alkenil, aril(C2-6)alkinil, cikloalkil(C1-6)alkil, heterociklo(C1-6)alkil, hidroksil(C1-6)alkil, amino(C1-6)alkil, karboksi(C1-6)alkil, alkoksi(C1-6)alkil, nitro, amino, ureido, cijano, alkilkarbonilamino, hidroksil, tiol, alkilkarboniloksi, azido, alkoksi, karboksi, aminokarbonil, i C1-6alkiltiol te je poželjno supstituirana sa halo, halo(C1-6)alkil, halo2(C1-6)alkil, halo3(C1-6)alkil, hidroksil(C1-6)alkil, amino(C1-6)alkil, hidroksil, nitro, C1-6alkil, C1-6alkoksi i amino, B je (CH2)m pri čemu m je cijeli broj 0 do 12, te poželjno 1, 2 ili 3; R3 i R4 su svaki nezavisno odabrani iz skupine koja sadrži aril i heteroaril; R5 je H, C1-6alkil, -C(=O)NHC1-6alkil, -C(=O)N(C1-6alkil)2 ili alkilaminokarbonil; i njegove farmaceutski prihvatljive soli i solvati. Patent sadrži još 16 patentnih zahtjeva.
Patent HR-P20120643-T1 (HR)
Inventor: ALBERTO GIMONA
IPC: A61P19/02
Filed: 2012-08-08
Abstract: Spoj FGF-18 za uporabu kod liječenja poremećaja hrskavice naznačen time da se spoj FGF-18 daje tijekom barem 3 uzastopna tjedna po ciklusu terapije, te su navedena davanja odvojena sa oko najmanje 6, 7 ili 8 dana. Patent sadrži još 14 patentnih zahtjeva.
Patent SI-1406869-T1 (SI)
Title: Taxol enhancer compounds
Inventor: KOYA KEIZO
IPC: A61K31/00
Filed: 2002-07-10
Abstract: Disclosed is a compound represented by the Structural Formula (I)   
Y is a covalent bond, a phenylene group or a substituted or unsubstituted straight chained hydrocarbyl group. In addition, Y, taken together with both >C=Z groups to which it is bonded, is a substituted or unsubstituted aromatic group. Preferably, Y is a covalent bond or -C(R 7 R 8 )-. R 1  and R 2  are independently an aryl group or a substituted aryl group, R 3  and R 4  are independently -H, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group. R 5 -R 6  are independently -H, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group. R 7  and R 8  are each independently -H, an aliphatic or substituted aliphatic group, or R 7  is -H and R 8  is a substituted or unsubstituted aryl group, or, R 7  and R 8 , taken together, are a C2-C6 substituted or unsubstituted alkylene group. Z is =O or =S. Also disclosed are pharmaceutical compositions comprising the compound of the present invention and a pharmaceutically acceptable carrier or diluent. Also disclosed is a method of treating a subject with cancer by administering to the subject a compound of Structural Formula (I) in combination with paclitaxel or an analog of paclitaxel.
Patent SI-2085610-T1 (SI)
Title: Vertical axis wind turbine with control system and method of aerodynamic braking
Inventor: COLLING CLAUS
IPC: F03D7/00
Filed: 2008-01-29
Abstract: The controller comprises a component with a spring element to pre-stress an aerodynamic brake towards a run-in position. Another component has a mass element (5) to move out the aerodynamic brake through a centrifugal force caused through an adequate high rotation of a rotor blade-segment against the pre-stress of the spring element. A third component (7) has an actuator which is connected with the aerodynamic brake and actuated to move out the aerodynamic brake against the pre-stress of the spring element. An independent claim is included for a method for aerodynamic braking in a wind energy system.